Biodesix, Inc. provided revenue guidance for the year 2024. The company anticipates generating between $65 million to $68 million in total revenue in 2024, representing an approximate 32% to 39% year-over-year growth rate.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 USD | +6.21% | +6.88% | -7.07% |
May. 21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.07% | 248M | |
-15.37% | 8.65B | |
+68.94% | 4.34B | |
+0.35% | 2.69B | |
+3.72% | 2.66B | |
-55.09% | 1.8B | |
-18.60% | 1.68B | |
-21.23% | 1.42B | |
+15.60% | 1.19B | |
-49.14% | 1.03B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix, Inc. Provides Revenue Guidance for the Year 2024